Boost for analysts
The ASX has extended its trial equity research subsidy program for another year after 60per cent of the companies covered reported an increase in turnover of their securities in the past year. The scheme was introduced to help smaller companies get analyst coverage, and for larger research houses to cover companies that they would otherwise ignore.
The ASX has extended its trial equity research subsidy program for another year after 60per cent of the companies covered reported an increase in turnover of their securities in the past year. The scheme was introduced to help smaller companies get analyst coverage, and for larger research houses to cover companies that they would otherwise ignore.
Want access to our latest research and new buy ideas?
Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.
Sign up for free